Early Red Blood Cell Transfusion Strategy in Septic Shock Among Cancer Patients: Insights from the TRANSPORT Randomized Controlled Trial
Highlights
- The TRANSPORT trial is a multicenter randomized controlled study focusing on red blood cell transfusion strategies in cancer patients with septic shock.
- No superiority of liberal (hemoglobin threshold 9.0 g/dL) compared to restrictive (threshold 7.0 g/dL) transfusion was demonstrated in terms of 12-hour lactate reduction or 28-day mortality.
- Liberal transfusion was associated with significantly increased arterial and venous thrombotic events.
- Evidence supports no routine preference for either transfusion strategy; individualized clinical decisions are necessary.
Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.